{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00533",
      "entity_text" : "EGFR",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_1511" ],
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0569" ]
    }
  },
  "verbose_text" : "To explore whether targeting CK2 eliminates icotinib-resistance, the basal protein expression of the catalytic CK2 subunit and EGFR were assessed in the four aforementioned lung adenocarcinoma cell lines with different EGFR genotypes, namely, A549 (wild-type EGFR), HCC827 (EGFR E716-A750del), NCI-H1975 (EGFR L858R+ T790M) and NCI-H1650 (EGFR E716-A750del and PTEN lost).",
  "reading_complete" : "2020-08-03T13:31:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:30:16Z",
  "trigger" : "expression",
  "evidence" : [ "expression of the catalytic CK2 subunit and EGFR" ],
  "pmc_id" : "6605624",
  "score" : 0
}